Clinical Trial Update: REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors [NA]

View source ↗

Summary

A ClinicalTrials.gov update for REVITALIZE, a randomized trial to reduce fatigue in adults with ovarian cancer on PARP inhibitors; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Advanced Ovarian Carcinoma | NA | Status: RECRUITING